Met-enkephalin alteration in the rat during chronic injection of morphine and/or midazolam

Brain Research

Volumn 775, Issue 1-2, 1997, Pages 119-126

  Tejwani, Gopi A ^a   Rattan, Anil K ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Benzodiazepine; Brain region; Central nervous system; Met enkephalin; Midazolam; Morphine; Opioid; Peripheral tissue; Spinal cord; Tolerance

Indexed keywords

METENKEPHALIN; MIDAZOLAM; MORPHINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG TOLERANCE; HYPOPHYSIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDULLA OBLONGATA; MESENCEPHALON; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-ANXIETY AGENTS; ENKEPHALIN, METHIONINE; MALE; MIDAZOLAM; MORPHINE; NARCOTIC ANTAGONISTS; NARCOTICS; NERVE TISSUE PROTEINS; PITUITARY GLAND; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0031461707     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00875-5     Document Type: Article

References (46)

1. Aghajanian G.K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. Audigier Y., Mazarguil H., Gout R., Cros J. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia. Eur. J. Pharmacol. 63:1980;35-46.
3. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7:1984;309-338.
4. Baxter M.G., Goff D., Miller A.A., Saunders I.A. Effect of a potent synthetic opioid pentapeptide in some antinociceptive and behavioral tests in mice and rats. Br. J. Pharmacol. 63:1980;35-46.
5. Beaumont A. Putative peptide neurotransmitters: the opioid peptides. Int. Rev. Exp. Pathol. 25:1983;279-305.
6. Bozarth M.A. Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system. Behav. Brain Res. 22:1986;107-116.
7. Bronstein D.M., Przewlocki R., Akil H. Effects of morphine treatment on proopiomelanocortin system in rat brain. Brain Res. 519:1990;102-111.
8. Cador M., Taylor J.R., Robbins T.W. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology. 104:1991;377-385.
9. Chang J.K., Fong B.T.W., Pert A., Pert C.B. Opiate receptor affinities and behavioral effects of enkephalin: structure-activity relationship of ten synthetic peptide analogues. Life Sci. 18:1976;1473-1482.
10. Childers S.R., Simantov R., Snyder S.H. Enkephalin: radioimmunoassay and radioreceptor assays in morphine dependent rats. Eur. J. Pharmacol. 46:1977;289-293.
11. Cuello A.C. Central distribution of opioid peptides. Br. Med. Bull. 39:1983;11-16.
12. Duka T., Wuster M., Herz A. Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam. Naunyn Schmiedeberg's Arch. Pharmacol. 309:1979;1-5.
13. Elsworth J.D., Redmond D.E. Jr., Roth R.H. Effects of morphine treatment and withdrawal on endogenous methionine- and leucine-enkephalin levels in primate brain. Biochem. Pharmacol. 35:1986;3415-3417.
14. Fratta W., Yang H.Y.T., Hong J., Costa E. Stability of met-enkephalin content in brain structures of morphine-dependent or foot shock stressed rats. Nature. 268:1977;452-453.
15. Gudehithlu K.P., Tejwani G.A., Bhargava H.N. β-Endorphin and met-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res. 553:1991;284-290.
16. Graybiel A.M., Chesselet M.F. Compartmental distribution of striatal cell bodies expressing met-enkephalin-like immunoreactivity. Proc. Natl. Acad. Sci. USA. 81:1984;7980-7984.
17. Graybiel A.M., Ragsdale C.W. Jr. Fiber connections of the basal ganglia. Prog. Brain Res. 51:1979;239-283.
18. 5-enkephalin elicited by depolarization. J. Pharmacol. Exp. Ther. 200:1982;616-620.
19. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-579.
20. 8-in the rat cerebellum. Neurosci. Lett. 91:1988;131-135.
21. Kreek M.J. Opiates, opioids and addiction. Mol. Psychiatry. 1:1996;232-254.
22. Kuriyama K., Yoneda Y. Morphine induced alterations of γ-aminobutyric acid and turine contents and L-glutamate decarboxylase activity in rat spinal cord and thalamus: possible correlates with analgesic action of morphine. Brain Res. 148:1978;163-179.
23. A receptor function. Psychopharmacology. 101:1990;545-549.
24. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
25. 2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides. 11:1990;969-972.
26. Naughton N., Hoffman W.E., Larscheid P., Cook J.M., Albrecht R.F., Miletich D.J. A benzodiazepine antagonist inhibits the cerebral-metabolic and respiratory depressant effects of fentanyl. Life Sci. 36:1985;2239-2245.
27. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12:1992;2439-2450.
28. 5-enkephalinamide into the ventral tegmental area. Behav. Brain Res. 5:1982;225-229.
29. Przewlocki R., Hollt V., Duka T., Kleber G., Gramsch C., Hoarmann I., Herz A. Long term morphine treatment decreases endorphin levels in rat brain and pituitary. Brain Res. 174:1979;357-361.
30. Rattan A.K., McDonald J.S., Tejwani G.A. Differential effects of intrathecal midazolam on morphine induced antinociception in the rat: role of spinal opioid receptors. Anesth. Analg. 73:1991;124-131.
31. Rattan A.K., Koo K.L., Tejwani G.A., Bhargava H.N. The effect of morphine tolerance-dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res. 584:1992;207-212.
32. Rattan A.K., Tejwani G.A. Effect of chronic treatment with morphine, midazolam and both together on β-endorphin levels in the rat. Brain Res. Bull. 41:1996;335-341.
33. Rattan A.K., Tejwani G.A. Effect of chronic treatment with morphine, midazolam and both together on dynorphin (1-13) levels in the rat. Brain Res. 754:1997;239-244.
34. Sheu M.J., Sribanditmongkol P., Tejwani G.A. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord. Brain Res. 675:1995;31-37.
35. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
36. Sribanditmongkol P., Sheu M.J., Tejwani G.A. Inhibition of morphine tolerance and dependence by diazepam and its relation to the CNS met-enkephalin levels. Brain Res. 645:1994;1-12.
37. R.K. Stoelting, Benzodiazepines, in: R.K. Stoelting (Ed.), Pharmacology and Physiology in Anesthetics Practice, Lippincott, Philadelphia, PA, 1991, pp. 126-129.
38. R.J. Tallarida, R.B. Murray (Eds.), Manual of Pharmacological Calculations with Computer Programs, 2nd ed., Springer-Verlag, New York, 1987.
39. Tejwani G.A., Vaswani K.K., Barbacci J.C. Effect of oral contraceptives on the rat brain and pituitary opioid peptides. Peptides. 6:1985;555-561.
40. Tejwani G.A., Rattan A.K., Sribanditmongkol P., Sheu M., Zuniga J., McDonald J.S. Inhibition of morphine-induced tolerance and dependence by a benzodiazepine receptor agonist midazolam in the rat. Anesth. Analg. 76:1993;1052-1060.
41. Tejwani G.A., Rattan A.K., Koo K.L., Matwyshyn G.A., Bhargava H.N. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50, 488H tolerant and abstinent rats. Pharmacology. 48:1994;216-225.
42. Tejwani G.A., Sribanditmongkul P., Sheu M.J. Inhibition of morphine tolerance and dependence by diazepam and its relation to CNS opioid peptides. Regul. Pept. 54:1994;299-300.
43. G.A. Tejwani, Opioid receptors, in: G. Jagadeesh (Ed.), Pharmacology of Receptors and Ion Transporters, M/S S.S. Publ., Ootocamund, 1996, pp. 119-136.
44. Weber E., Roth K.A., Barchas J.D. Immunohistochemical distribution of neoendorphin/dynorphin neuronal systems in rat brain: evidence for colocalization. Proc. Natl. Acad. Sci. USA. 79:1983;3062-3066.
45. Wesche D., Hollt V., Herz A. Radioimmunoassay of enkephalin. Regional distribution in rat brain after morphine treatment and hypophysectomy. Naunyn Schmiedeberg's Arch. Exp. Pathol. Pharmacol. 301:1977;79-82.
46. M. Wood, Intravenous anesthetic agents, in: M. Wood, A.J.J. Wood (Eds.), Drugs and Anesthesia, Williams and Wilkins, Baltimore, MD, 1990, pp. 201-204.